Treatment of relapsed or refractory AML with intermediate-dose arabinosylcytosine (ara-c): Confirmation of the importance of ara-c triphosphate formation in mediating response to ara-c

Elihu H. Estey, William Plunkett, Hagop Kantarjian, Mary Beth Rios, Michael J. Keating

Research output: Contribution to journalArticlepeer-review

11 Scopus citations
Original languageEnglish (US)
Pages (from-to)115-121
Number of pages7
JournalLeukemia and Lymphoma
Volume10
Issue numberS1
DOIs
StatePublished - 1993

Keywords

  • Acute myelogenous leukemia arabinosylcytosine
  • Complete remission
  • Toxicity

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this